Bankers reckon that Archegos’s net capital -- essentially Hwang’s wealth -- had reached north of $10 billion. 9540 Towne Centre DriveSuite 100San Diego, CA 92121United States858 888 7600http://bionanogenomics.com, Sector(s): HealthcareIndustry: Diagnostics & ResearchFull Time Employees: 147. a buyer finding a seller, or a seller finding a buyer). Following Bionano’s presentation at Oppenheimer’s Annual Healthcare Conference, firm analyst Kevin DeGeeter talked with management to learn what’s in-store for the company. Bionano Genomics provides unparalleled structural variation detection for genetic disease research, cancer research & cytogenomics with genome imaging technology. 7.75 +0.03 (0.39%)After hours: 5:21PM EDT, Subscribe to Premium to view Fair Value for BNGO. (See SVRA stock analysis on TipRanks) Aquestive Therapeutics (AQST) Next up, Aquestive Therapeutics, is a diversified biotech firm with a range of products in all stages of the development pipeline, from pre-clinical to fully approved and on the market. The Japanese firm has begun assessing the cause of the possible loss tied to the client, said an executive, asking not to be identified.It’s too early to determine how it might impact profit, when Nomura can calculate the extent of any loss and whether it would book a charge for the current quarter, the executive said. The implication for investors? -Solidified Financial Position Raising Approximately $335 Million in Q1 2021 -Executed on Commercial Offerings for Saphyr®, Driving Towards Global Adoption -Conference Call Today, March 23, 2021, at 4:30 pm EST SAN DIEGO, March 23, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported … Therefore, even minor upward movements could result in massive percentage gains, and thus, significant returns. Words such as “may,” “will,” “expect,” “plan,” “anticipate,” “estimate,” “intend” and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) convey uncertainty of future events or outcomes and are intended to identify these forward-looking statements. Bionano Genomics is scheduled to hold the call at 16:30:00 ET and can be accessed here. The Saphyr system is comprised of an instrument, chip consumables, reagents and a suite of data analysis tools. Still, the rebound was modest.Phil Rush, at research firm Heteronomics, a Malvern, England-based financial research firm, isn’t convinced about such a recovery. The trade represented a $16,500 bullish bet for which the trader paid 45 cents per option contract. For some, better days are on the horizon, and for very little money, investors can control a lot more shares. “[The] company recently gained clarity from the FDA on the acceptability of the company’s revised proposed weight-based dosing regimen, in combination with new modeling and simulations, in a Type A meeting in October 2020 and the company’s subsequent submission of the planned dosing regimen and modeling in December. Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover, Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time Price. “The spring sowing season is unlikely to see major changes from recent years because farmers have these constraints.”Read more about Russia’s grain-export curbs and planned measures for sunflower oil.Major farm company Ros Agro Plc in February said it would cut grains planting this year, without elaborating, while Steppe Agroholding, one of the top producers in southern Russia, plans to keep sowing steady. Bionano’s Saphyr system is a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. (Updates with Credit Suisse details in 10th paragraph. Together, the traders are betting $223,500 that the share price of Kratos is going higher. He says savings have been accumulated by households least likely to spend them, and there’s no sign of any likely spending splurge.”The longer-term picture is far less positive” for the pound, said Antony Foster, head of G-10 spot trading at Nomura International Plc in London. Investors need to pay close attention to Bionano Genomics (BNGO) stock based on the movements in the options market lately. The trade represented a $15,700 bullish bet for which the trader paid 55 cents per option contract. An earlier version added a podcast link and Malaysian data. Despite once working for Robertson’s Tiger Management, he wasn’t well-known on Wall Street or in New York social circles.Hwang is a trustee of the Fuller Theology Seminary, and co-founder of the Grace and Mercy Foundation, whose mission is to serve the poor and oppressed. Investors on Reddit, mainly on the forum that participated in a short squeeze in the shares of GameStop Corporation (NYSE: GME), are laying the finger of blame on Wall Street big shots for the plunge that affected several companies Friday. Now, our Lineagen team can better interpret these VUS using our proprietary NeuroSCORE algorithm to diagnose more patients and provide more conclusive answers to families of patients with neurodevelopmental disease. Share your opinion and gain insight from … About Bionano GenomicsBionano is a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing, and providing diagnostic testing for those with autism spectrum disorder (ASD) and other neurodevelopmental disabilities through its Lineagen business. It’s no wonder Wood’s space and innovation focused ETF has bought shares of the company. What Happened: Multiple posts from Reddit users including on r/WallStreetBets bemoaned the unfairness of the situation where retail investors using social media were allegedly blamed for risky trading while institutional investors were the ones that were overleveraged. “We are now moving into what I believe will be prime time,” she said. These advances may make it possible to better study the complex molecular mechanisms for conditions such as autism spectrum disorder and other disorders of childhood development, which are often caused by a combination of genetic variants affecting multiple genes and pathways. Click here for options trades from Benzinga, 12 Health Care Stocks Moving In Tuesday's After-Market Session. Ansys Inc (NASDAQ: ANSS): engineering software company that provides simulation capabilities for more than 50,000 customers globally including the aerospace and defense sectors. In 2019, AMC generated a net loss of $149.1 million on $5.47 billion in revenue. “Following Praxis’ CAP accreditation, we believe that the assignment of MolDX Z-codes for Saphyr testing is an important next step to enable more widespread reimbursement of OGM by private and public payers. The company’s lead drug candidate, molgradex, is an inhalant medication designed as a granulocyte-macrophage colony-stimulating factor; in short, it is targeted on the autoimmune flaw that prevents the body’s natural self-cleansing of the lungs. Tulpova Zuzana, Tel Aviv University Poster Presentation – Technology DevelopmentTuesday, March 2 – 3:30P-5:30P (EST)Identifying Polymorphic Variants at Complex Regions Using Optical Genome MappingDr. ETF provider Simplify Asset Management filed just last month to list an exchange-traded fund that shorts VIX futures.It all signals the return of betting on tranquil markets after the VIX spiked to a record last March -- sparking blowups for the riskiest versions of the trade.Led by Allan Kennedy and Ken Kwalik, Carrick Lane will pursue put-writing strategies to take advantage of the volatility-risk premium. Praxis is the first CAP-accredited, CLIA-certified diagnostic lab in the United States to develop and offer commercially an LDT based on whole genome analysis with Saphyr. Kratos refers to the technology as an “infrastructure gamechanger” in the release. To this end, Rahimi rates SVRA an Overweight (i.e. “2021 is shaping up to be a transformational year for the company. The decrease was driven by primarily by customers limiting their lab operations in response to COVID-19 restrictions and the introduction of our reagent rental program, partially offset by $1.6 million increase in services revenue. Factors that may cause such a difference include the risks and uncertainties associated with: the impact of the COVID-19 pandemic on our business and the global economy; general market conditions; changes in the competitive landscape and the introduction of competitive products; changes in our strategic and commercial plans; our ability to obtain sufficient financing to fund our strategic plans and commercialization efforts; the ability of medical and research institutions to obtain funding to support adoption or continued use of our technologies; the loss of key members of management and our commercial team; and the risks and uncertainties associated with our business and financial condition in general, including the risks and uncertainties described in our filings with the Securities and Exchange Commission, including, without limitation, our Annual Report on Form 10-K for the year ended December 31, 2019 and in other filings subsequently made by us with the Securities and Exchange Commission. The Saphyr system is capable of handling Praxis’ sample workload after the latest updates to the system enabled it to map 96 human samples per week, or about 5,000 per year. It’s slipped more than 1% in March so far, on track to interrupt an advance since September that drove it to its strongest level in almost three years.“Too much optimism may be in the price,” said London-based Mark Dowding, who this month reopened bets against the pound at BlueBay Asset Management LLP, where he oversees $70 billion. The trade represented a $138,200 bullish bet for which the trader paid $4.80 per option contract. We view these activities as readily accomplishable..." Butler noted. “OGM complements even the most advanced sequencing technology and plays an essential role in identifying large structural variants, including those in the most complex parts of the genome, as the authors of this study pointed out. Some companies considered reviewing their acreage mix, but that’s a risk given export restrictions on other crops too, Steppe Chief Executive Officer Andrey Neduzhko said.The taxes are intended to help consumers by keeping domestic prices in check, but risk curbing farmer incomes as the supply chain absorbs the levies.That’s especially the case for smaller farmers, who unlike big agriculture holdings aren’t partly shielded by their size and diversification. Revenue guidance hasn't been issued by the company for now. Lastly, the company said that via a combination of better hardware capabilities and software updates that lower the amount of consumables required for each run, Bionano can achieve the goal of a $100 per genome cost in the next-gen Saphyr. With a platform such as Saphyr, McCarthy says, the technology could provide new insights into cancer testing for solid tumors, which in the oncology field, is the biggest clinical and research market. The content is intended to be used for informational purposes only. Gross Margin Gross margin for the fourth quarter of 2020 was 30%, down 9% from 39% in the same period in 2019. AeroVironment (NASDAQ: AVAV): an unmanned aircraft systems, tactical missile systems and satellite company serving the U.S. government and international governments. Looking forward to a successful resubmission, Butler rates Aquestive’s shares an Outperform (i.e. About Bionano GenomicsBionano is a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing, and providing diagnostic testing for those with autism spectrum disorder (ASD) and other neurodevelopmental disabilities through its Lineagen business. A sweeper pays market price for the call options instead of placing a bid, which sweeps the order books of multiple exchanges to fill the order immediately. Building that reference, scientists have carried out many sequencing projects over the last 20 years to identify and catalog genetic differences between an individual and the reference genome. Workhorse Group (NASDAQ: WKHS): an electric vehicle company that also has a drone business seeking FAA certification. All rights reserved. The firm’s London-based subsidiary, MUFG Securities EMEA, posted a profit of just 84 million pounds ($116 million) in 2019, according to the most recent filing available from the U.K. Companies House. KTOS Price Action: Shares of Kratos were up 6.3% at $27.66 at last check. Bionano Genomics, Inc. (BNGO) closed at $9.84 in the latest trading session, marking a +1.13% move from the prior day. At 10:18 a.m., a trader executed a call sweep of 151 Kratos options with a $30 strike price expiring on April 16. The short squeeze sent the stock skyrocketing from under $2 per share to as high as $20.36 in a matter of days. “The lockdown in the U.K. remains more restrictive than elsewhere,” putting the shackles on growth.The pessimism underscores the mounting difficulties faced by Prime Minister Boris Johnson. If stocks stay steady or rise, the investor keeps the premium received and the options expire worthless.The risk is that equities fall and the option is exercised, compelling the seller to purchase the shares at the strike price.That contrasts with the short-volatility trades pursued by the likes of Malachite, which used over-the-counter derivatives and leverage that ultimately led to its liquidation in the unprecedented market rout.Such strategies went into abeyance post-Covid as risk appetite fell. Xilinx Inc (NASDAQ: XLNX): a leader in the field-programmable gate array circuit market that designs and sells chips to third party companies. These types of call option orders are usually made by institutions, and retail investors can find watching for sweepers useful because it indicates “smart money” has entered into a position. Bionano Genomics, Inc. (BNGO) Add to watchlist. Shares of Nomura fell again Tuesday, a day after dropping a record 16%.For its part, Credit Suisse has said that while it was premature to quantify the size of its loss, it may be “highly significant and material to our first quarter results.”In the U.S., Wall Street banks grappling with the meltdown of Hwang’s investment firm spent Monday briefing regulators. Many of these large SVs consisted of more complex rearrangements or overlap with large repetitive areas called segmental duplications which are associated with developmental delay and adult neuropsychiatric disease, highlighting the importance of OGM in genome structure analysis. He predicted regulators will examine whether “there should be more transparency and disclosure by a family office.”Without the need to market his fund to external investors, Hwang’s strategies and performance remained secret from the outside world. This target suggests shares could soar 309% in the next year. All rights reserved. Since the dust has settled on the initial short squeeze, AMC shares are now back down to the $10.63 level. Description. 7.43 … For more information to understand options alerts, visit https://pro.benzinga.help/en/articles/1769505-how-do-i-understand-options-alerts See more from BenzingaClick here for options trades from Benzinga12 Health Care Stocks Moving In Monday's After-Market Session10 Health Care Stocks With Unusual Options Alerts In Today's Session© 2021 Benzinga.com. The increase was primarily due to a $1.1 million increase in service revenue contributed primarily by our Lineagen subsidiary.Revenues for the year ended December 31, 2020 were $8.5 million, down $1.6 million from $10.1 million in 2019. Since hitting this bottom, the tech-heavy Nasdaq Composite has more than doubled, while the broad-based S&P 500 has gained as much as 77%. The installed base of Saphyr systems was 97 at the end of the year, an increase of 24 from year-end 2019. NasdaqCM - NasdaqCM Real-time price. Atlas Crest Investment Corp (NYSE: ACIC): a SPAC taking Archer, an eVTOL company, public. “Saphyr is a platform technology, and key to driving adoption by institutions is to demonstrate applicability across a wide range of disease areas,” the 5-star analyst said. Elbit Systems (NASDAQ: ELST): produces products for defense, homeland security and commercial flight companies. Factors that may cause such a difference include the risks and uncertainties associated with: the impact of the COVID-19 pandemic on our business and the global economy; general market conditions; changes in the competitive landscape and the introduction of competitive products; changes in our strategic and commercial plans; our ability to obtain sufficient financing to fund our strategic plans and commercialization efforts; the ability of medical and research institutions to obtain funding to support adoption or continued use of our technologies; the loss of key members of management and our commercial team; and the risks and uncertainties associated with our business and financial condition in general, including the risks and uncertainties described in our filings with the Securities and Exchange Commission, including, without limitation, our Annual Report on Form 10-K for the year ended December 31, 2019 and in other filings subsequently made by us with the Securities and Exchange Commission. The average price target among the seven analysts covering the stock is $2, suggesting 81% downside from current levels. Praxis once again is the first U.S. laboratory to pass this milestone, and we believe other U.S. labs will follow in Praxis’ footsteps over time and build the path towards reimbursement. Consumers did return to online and in-store shopping in February after a slump at the beginning of the year, official figures published Friday showed. Spirit AeroSystems Holdings Inc (NYSE: SPR): commercial aerospace designer and manufacturer of items such as fuselage systems, propulsion systems and wing systems. Currency in USD. Investors are expected to pocket a 69% gain if the analyst’s thesis materializes. CONTACTSCompany Contact:Erik Holmlin, CEOBionano Genomics, Inc.+1 (858) 888-7610eholmlin@bionanogenomics.com Investor Relations Contact:Ashley R. RobinsonLifeSci Advisors, LLC+1 (617) 430-7577arr@lifesciadvisors.com Media Contact:Darren Opland, PhDLifeSci Communications+1 (617) 733-7668darren@lifescicomms.com, Article published in Science reveals that optical genome mapping uniquely makes thousands of large structural variant callsSAN DIEGO, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced the publication in Science of a study by the Human Genome Structural Variation Consortium (HGSVC) that used a combination of advanced sequencing and optical genome mapping (OGM) with Saphyr to assemble with high resolution and structural accuracy 64 haplotype-resolved human genomes from 32 individuals representing 25 different populations. It has adapted the film delivery system for dosing through several locations in the mouth, including inside the cheek, under the tongue, and on the tongue. Benzinga does not provide investment advice. Aquestive uses a unique film-based delivery mechanism for its medications. We do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise. Libervant, dosed through a buccal (inside the cheek) film, was designed to treat seizure clusters. #Crypto Demand. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things: the potential for NeuroSCORE to enable discovery of novel genes and improve diagnostic capabilities for patients with genetic disease, including neurodevelopment disease; our beliefs regarding the potential benefits of integrating NeuroSCORE with Bionano’s existing Saphyr technology; the contribution of expertise and resources from Lineagen to the advancement of current and future applications for our Saphyr system; and the execution of Bionano’s strategic plans. However, AMC experienced a near worst-case scenario in March 2020. https://viavid.webcasts.com/starthere.jsp?ei=1438152&tp_key=1a103232b0, EQT Nears $5.3 Billion Deal for Partners Group’s Cerba, How Democrats will squeeze pharma to pay for spending plans, Texas Moves to Kill Gas Bans Proposed by Austin, Pressure mounts on financial regulators to address Archegos debacle, Oil Slips With Strong Dollar Compounding Worsening Virus Outlook, BlueBay’s Pound U-Turn Signals U.K. Post-Brexit Pain Starts Now, Russian Farmers Undeterred by Export Crackdown, at Least for Now, Volatility Selling Is Back as Ex-Harvest Traders Join Fray, One of World’s Greatest Hidden Fortunes Is Wiped Out in Days, Stimulus checks coming for some Social Security recipients and other federal beneficiaries, IRS says, China Recovery May Buoy Emerging Markets After Volatile Week, No IRS stimulus check? View more earnings on BNGO If the company were to match the consensus estimate when it reports Tuesday, earnings would be up 78.26%. Total earnings, which is also referred to as net income, equals total revenue minus total expenses. After their long positions hit a one-year high earlier in March, leveraged funds scaled back their wagers for a third-straight week.Even with a Brexit deal and an agreement on financial regulation out of the way, the U.K.’s departure from the EU has ushered in a fresh series of risks, including tension on the Irish border and a possible referendum on Scottish independence.Brexit will bring “a slowdown in potential growth, so from a longer-term perspective we would expect sterling to resume its downward trend,” said Seema Shah, the chief strategist at Principal Global Investors in London who sees the pound retreating to $1.30 as early as the third quarter. Bionano Customer Praxis Genomics Receives DEX Z-Codes from Palmetto for their Whole Genome Analysis LDT on Saphyr. AGBT will be held virtually at https://www.agbt.org/ March 1-3. Bionano Genomics (NASDAQ:BNGO) announces its next round of earnings this Tuesday, March 23. The budget deficit is set to hit about 15% of GDP this fiscal year, the highest since the Second World War.For Dowding, that means sterling may retreat more than 5% to $1.30 in the next three months, a level last seen in November -- when markets were being rattled by doubts over whether a Brexit deal could be reached. Bionano’s Saphyr system is a research use only platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. Back. As an actively managed ETF, the holdings could change over the coming days. Bionano Genomics (BNGO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. “This not only improves the ability of Lineagen's genetic counselors to interpret variants of unknown significance (VUS),” McCarthy noted, “But can be integrated into Saphyr to quickly filter SVs based on risk of causing CNS disease.” All in all, McCarthy rates BNGO a Buy along with a $14 price target. The trade represented a $10,400 bullish bet for which the trader paid 50 cents per option contract. Investors who have owned stocks in the past year have generally experienced some big gains. AMC investors who bought one year ago and held on were completely bailed out by the short squeeze and have now generated an impressive return on their investment. The decrease was primarily due to approximately $400 thousand in one time charges related to year end accounting.Gross margins for the year ended December 31, 2020 were 33%, consistent with 2019. Potential gains of 62% on the one-year time horizon. About Bionano GenomicsBionano is a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing, and providing diagnostic testing for those with autism spectrum disorder (ASD) and other neurodevelopmental disabilities through its Lineagen business. The study followed 128 patients over periods between 48 and 72 weeks, and showed improvements on two independent measures of gas exchange in the lungs. told CNBC that Reddit-fueled trading wasn’t fair or orderly and posed a “systemic risk.” For news coverage in Italian or Spanish, check out Benzinga Italia and Benzinga España. Last week, the gauge closed as low as 18, down from its record closing high of 82 last March. Some parts of this page is not supported on your current browser version.